Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by KALLQVIST, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by KALLQVIST, I.
(Chest. 1955;28:465-468.)
© 1955 American College of Chest Physicians

A New Method for Producing Pleural Symphysis in Spontaneous Pneumothorax

REPORT OF A CASE TREATED WITH STREPTOKINASE-STREPTODORNASE

IVAR KALLQVIST M.L.1

1 Physician-in-Chief, Löt Sanatorium, Strängnäs, Sweden.

Past and current methods of treating spontaneous pneumothorax are briefly reviewed, and a case is presented in which pleural obliteration was achieved by intrapleural instillation of varidase (streptokinase-streptodornase). The patient was a 36-year-old man with a 20-year history of recurrent episodes of non-hemorrhagic spontaneous pneumothorax.

Vanidase appears to evoke generalized pleural irritation. With judicious dosage and continuous suction drainage and breathing exercises, the (see the figure in the source pdf) method would appear to merit trial in relapsing spontaneous pneumothorax.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1955 by the American College of Chest Physicians.